Notably, Brusatol, a natural NRF2 inhibitor, enhances the binding of KEAP1 to NRF2, promotes NRF2 ubiquitination, and accelerates its proteasomal degradation, thereby suppressing NRF2-driven antioxidant function and sensitizing cancer cells to oxidative stress. This evidence concerns the gene NFE2L2 and cancer.